Effectiveness of treatment programmes for depression among adults with mild/moderate intellectual disability

Journal of Intellectual Disability Research : JIDR
Marita P McCabeD C Newton

Abstract

The current study describes the development and evaluation of group treatment programme for people with mild/moderate intellectual disability (ID). A total of 34 participants (16 males, 18 females) completed the treatment programme and 15 participants (six males, nine females) comprised a control group. Compared to the control group, the intervention group showed an improvement in levels of depression, positive feelings about the self, and lower levels of automatic negative thoughts after the intervention. These changes were maintained at 3-month follow-up. These results demonstrate that intervention programmes are effective for the treatment of depression among people with ID.

References

Feb 1, 1991·Journal of Consulting and Clinical Psychology·N S Jacobson, P Truax
Jun 1, 1993·The British Journal of Medical Psychology·W R LindsayD Pitcaithly
Jun 1, 1996·Journal of Intellectual Disability Research : JIDR·W Meins
Dec 1, 1996·Journal of Personality Assessment·A T BeckW Ranieri
Jan 16, 1998·Journal of Intellectual Disability Research : JIDR·G M MarstonA Roy
Nov 5, 1999·Journal of Intellectual Disability Research : JIDR·D Dagnan, S Sandhu
Aug 12, 2000·Research in Developmental Disabilities·J RoseD Clifford

❮ Previous
Next ❯

Citations

Aug 30, 2008·The Psychiatric Quarterly·Diana J Antonacci, Nadir Attiah
Nov 28, 2013·Journal of Intellectual & Developmental Disability·Noud Frielink, Petri Embregts
Apr 21, 2009·American Journal on Intellectual and Developmental Disabilities·Clare DavisNigel Beail
Mar 23, 2013·The British Journal of Psychiatry : the Journal of Mental Science·Paul WillnerKerenza Hood
Mar 12, 2011·Research in Developmental Disabilities·J C WalkerJ G E Janzing
Nov 6, 2007·Research in Developmental Disabilities·Jane A McGillivrayMavis M Kershaw
Dec 17, 2014·Journal of Intellectual Disability Research : JIDR·A JahodaC Davidson
May 29, 2013·Journal of Applied Research in Intellectual Disabilities : JARID·David AllenCraig Kennedy
Jan 1, 2014·Journal of Intellectual Disability Research : JIDR·J A McGillivray, M Kershaw
Mar 1, 2016·Journal of Mental Health Research in Intellectual Disabilities·Sigan L HartleyPaige Bussanich
Sep 21, 2013·Research in Developmental Disabilities·Leen Vereenooghe, Peter E Langdon
Apr 26, 2016·Journal of Intellectual Disability Research : JIDR·M Osugo, S-A Cooper
May 21, 2016·The British Journal of Psychiatry : the Journal of Mental Science·Nadine KoslowskiBernd Puschner
May 19, 2017·Journal of Intellectual Disabilities : JOID·Owen Doody, Maria E Bailey
Jan 21, 2017·Journal of Intellectual Disabilities : JOID·Neil E ClaptonRobert Sp Jones
Sep 29, 2018·Health Technology Assessment : HTA·Andrew JahodaCraig Melville
Oct 26, 2018·Journal of Applied Research in Intellectual Disabilities : JARID·Laura Surley, Dave Dagnan
Apr 12, 2016·The Cochrane Database of Systematic Reviews·Robert BaloghDaniela C Gonçalves-Bradley
Mar 20, 2013·Current Opinion in Psychiatry·Brian E McGuire, Susan Kennedy
Oct 18, 2012·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Peter Sturmey
Jun 17, 2020·Journal of Applied Research in Intellectual Disabilities : JARID·Janny Beernink, Gerben J Westerhof
May 26, 2018·Journal of Intellectual Disability Research : JIDR·P C M HamersH Hermans
Nov 18, 2020·The British Journal of Psychiatry : the Journal of Mental Science·Lauren A CameronKylie M Gray
Aug 3, 2021·Journal of Applied Research in Intellectual Disabilities : JARID·Jane BourneSimon Hackett

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.